Risk of severe illness from COVID-19 in patients with metabolic dysfunction-associated fatty liver disease and increased fibrosis scores

BMI, body mass index 95% CI, 95% confidence interval COVID-19, coronavirus disease 2019 FIB-4, fibrosis 4 index MAFLD, metabolic fatty liver disease NAFLD, nonalcoholic fatty liver disease NFS, NAFLD fibrosis score OR, odds ratio